|
|
|
|
|
|
|
|
|
The Wright Reports site is no longer hosted or operated by Manta. Please review
the following:
1. You have been redirected to CorporateInformation.com where you can view
Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to
www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on
to the member site:
http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact
help@corporateinformation.com, Contact phone nr to be provided later)
|
|
|
|
|
|
 |
|
|
|
|
|
|
 |
|
Sanofi S.A. - ADR
Company Snapshot
|
|
Business Description:
Sanofi S.A. - ADR operates in the Pharmaceutical preparations sector. Sanofi, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi focuses on the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. As of February 2011, Sanofi portfolio comprised 55 projects in clinical development, of which 13 were in Phase III or had been submitted to the health authorities for approval. Sanofi has a portfolio of prescription drugs, vaccines, generics and consumer healthcare products. In December 2011, Sanofi announced that it completed the divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International, Inc.
|
|
| |
|
| |
|
| |
|
|
|
|
|
|
|
| |
| |
Stock Data: |
Recent Stock Performance: |
|
| |
Current Price (2/3/2012):
36.73
(Figures in
U.S. Dollars) |
|
1 Week |
-0.6% |
|
13 Weeks |
2.3% |
|
 |
 |
 |
 |
 |
 |
|
4 Weeks |
7.6% |
|
52 Weeks |
6.8% |
|
|
|
| |
| |
Sanofi S.A. - ADR
Key Data: |
 |
|
| |
Ticker: |
SNY |
Country: |
FRANCE |
| |
 |
| |
Exchanges: |
NYSE |
Major Industry: |
Drugs, Cosmetics & Health Care |
| |
 |
| |
|
|
Sub Industry: |
Ethical Drug Manufacturers |
| |
 |
| |
2011
Sales |
46,666,803,630
(Year Ending Jan 2012). |
Employees: |
101,575 |
| |
 |
| |
Currency: |
U.S. Dollars |
Market Cap: |
98,464,314,800 |
| |
 |
| |
Fiscal Yr Ends: |
December |
Shares Outstanding: |
2,680,760,000 |
| |
 |
| |
Share Type: |
Actions Ordinaires |
Closely Held Shares: |
409,241,896 |
|
| |
|
| |
| |
|
|
|
CorporateInformation® website and selected data Copyright © 2000 -
by The Winthrop Corporation. All Rights Reserved. Except for quotations by established
news media, no pages on this site may be reproduced, stored in a retrieval system,
or transmitted for commercial purposes, in any form or by any means, electronic,
mechanical, photocopying, recording, or otherwise without prior written permission.
Information is believed reliable, but accuracy, completeness and opinions are not
guaranteed.
|
|
|
|
|